Trial-Results center  
Clinical trial results database Feedback    Home


Related trials

TRIANA, 2009 - primary ballon angioplasty vs tenecteplase

DEBATER (SES vs BMS), 2009 - sirolimus eluting stent vs bare-metal stent

NORDISTEMI, 2009 - thrombolysis + angioplasty vs immediate thrombolysis

Juwana, 2009 - sirolimus eluting stent vs paclitaxel eluting stent

ZEST AMI (vs PES), 2009 - zotarolimus eluting stent vs paclitaxel eluting stent

PASEO, 2009 - drug-eluting stents vs bare-metal stent

ZEST AMI (vs SES), 2009 - zotarolimus eluting stent vs sirolimus eluting stent

CARESS, 2008 - thrombolysis + angioplasty vs immediate thrombolysis

HORIZONS-AMI Stent, 2008 - paclitaxel eluting stent vs bare-metal stent

MISSION, 2008 - sirolimus eluting stent vs bare-metal stent

DEDICATION, 2008 - drug-eluting stents vs bare-metal stent

Díaz de la Llera, 2007 - sirolimus eluting stent vs bare-metal stent

SESAMI, 2007 - sirolimus eluting stent vs bare-metal stent

PROSIT, 2006 - sirolimus eluting stent vs paclitaxel eluting stent

HAAMU-STENT, 2006 - paclitaxel eluting stent vs bare-metal stent

PASSION, 2006 - paclitaxel eluting stent vs bare-metal stent

WEST, 2006 - systematic PCI (+stent) vs no systematic PCI

TYPHOON, 2006 - sirolimus eluting stent vs bare-metal stent

ZWOLLE 6, 2005 - primary stenting vs balloon angioplasty

CAPITAL AMI, 2005 - systematic PCI (+stent) vs no systematic PCI

senior PAMI, 2005 - primary PCI vs Thrombolysis

CAPITAL AMI, 2005 - thrombolysis + angioplasty vs immediate thrombolysis

Di Lorenzo et al., 2005 - sirolimus eluting stent vs paclitaxel eluting stent

GRACIA-1, 2004 - systematic PCI (+stent) vs no systematic PCI

MERLIN (Sutton), 2004 - immediate systematic ballon angioplastyte vs no immediate angioplasty



See also:

  • All acute myocardial infarction clinical trials
  • All clinical trials of PCI
  • All clinical trials of primary PCI
  •  

    senior PAMI study, 2005

    [NCT00136929] Facebook    pdf : primary PCI - myocardial revascularization for acute myocardial infarction

    Treatments

    Studied treatment primary percutaneous coronary intervention
    Control treatment intravenous thrombolytic therapy

    Patients

    Patients elderly (age >= 70 years) patients with acute myocardial infarction
    Exclusion criteria systolic blood pressure >180 mm Hg; diastolic blood pressure >100 mm Hg; warfarin

    Method and design

    Randomized effectives 252 / 229 (studied vs. control)
    Design Parallel groups
    Blinding Open
    Follow-up duration 30 days
    Primary endpoint death or disabling stroke


    Results

    Endpoint Studied treat.
    n/N
    Control treat.
    n/N
    Graph RR [95% CI]

    stroke (fatal and non fatal)

    2 / 252
    5 / 229
    0,36 [0,07;1,86]

    In-hospital death

    25 / 252
    30 / 229
    0,76 [0,46;1,25]
    0 2 1.0

    Relative risks
    Endpoint Events (%) Relative Risk 95% CI Endpoint definition
    in the trial
    Ref
    Studied treat. Control treat.
    In-hospital death 25 / 252 (9,9%) 30 / 229 (13,1%) 0,76 [0,46;1,25] at 30 days   
    stroke (fatal and non fatal) 2 / 252 (0,8%) 5 / 229 (2,2%) 0,36 [0,07;1,86] disabling at 30 days   
    The primary endpoint (if exists) appears in blod characters
    Reference(s) used for data extraction:

    Endpoint studied treat. control treat. mean diff

    Absolute risk reduction
    Endpoint Events rate Absolute risk
    reduction (ARR)
    Studied treat. Control treat.
    In-hospital death 9,92% 13,10% -31,8‰
    stroke (fatal and non fatal) 7,94‰ 2,18% -13,9‰

    Meta-analysis of all similar trials:

    myocardial revascularization in acute myocardial infarction for Elderly patients

    myocardial revascularization in acute myocardial infarction for all type of patients

    PCI in acute myocardial infarction for all type of patients

    PCI in acute myocardial infarction for Elderly patients



    Reference(s)

    Trials register # NCT00136929

    (c) 2004-2011 TrialResults-center - All Rights Reserved

    Tweet this  |  notify a friend